Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Single-blind, Randomized, Controlled, Multi-center Study to Evaluate the Efficacy and Safety of SRM003 (Vascugel®) in the Treatment of Subjects With Vascular Injury Resulting From Arteriovenous Graft Surgery for Hemodialysis Access

NCT01806584 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01806584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01806584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Single-blind, Randomized, Controlled, Multi-center Study to Evaluate the Efficacy and Safety of SRM003 (Vascugel®) in the Treatment of Subjects With Vascular Injury Resulting From Arteriovenous Graft Surgery for Hemodialysis Access
Lead sponsor
Shire
Phase
Phase 2
Overall status
Terminated
Start date
March 28, 2013
Completion date
October 23, 2014
Enrollment
32 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous graft